Patents by Inventor Jean-Luc CRACOWSKI

Jean-Luc CRACOWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210378995
    Abstract: Microvascular dysfunction remains a major contributor to the development of skin complications. The inventors assessed the impact of the local inhibition of soluble epoxide hydrolase (sEH), which metabolizes vasodilator and anti-inflammatory epoxyeicosanoids, on the diabetic skin microvascular dysfunction. The inventors have therefore developed some formulations of sEH inhibitors (GSK2256294 and t-AUCB) for topical administration. In particular, they show that an aqueous gel containing 400 mg/L t-AUCB dissolved in 50% dimethy lsulfo xide (DMSO) allowed a stable and continuous diffusion of t-AUCB from 2 hours after application on skin pig ears to over a period of 24 h. Compared to a control gel, the gel with t-AUCB did not significantly modify the basal skin blood flow but improved the altered hyperemic response of db/db mice 2 hours after application.
    Type: Application
    Filed: October 9, 2019
    Publication date: December 9, 2021
    Inventors: Jérémy BELLIEN, Frédéric BOUNOURE, Mohamed SKIBA, Yann SAVINA, Matthieu ROUSTIT, Jean-Luc CRACOWSKI
  • Patent number: 10874856
    Abstract: A device treats a region of the body of a patient having a cutaneous ulcer, including: a hydrogel, hydrocolloid, hydrocellular or hydrofiber primary dressing, impregnated with treprostinil, that can be shaped to the contours of the region to be treated, a so-called “active” electrode in contact with the primary dressing, a so-called “passive” electrode at a distance from the active electrode, a DC generator, the terminals of which are connected to the electrodes, the cathode and the anode respectively forming the active electrode and the passive electrode for iontophoresis, so as to cause treprostinil to migrate by cathodal iontophoresis into the region to be treated.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: December 29, 2020
    Assignees: Centre Hospitalier Universitaire Grenoble, Hopital Nord, Universite Joseph Fourier—Grenoble 1
    Inventors: Jean-Luc Cracowski, Matthieu Roustit, Sophie Blaise
  • Publication number: 20160158543
    Abstract: A device treats a region of the body of a patient having a cutaneous ulcer, including: a hydrogel, hydrocolloid, hydrocellular or hydrofiber primary dressing, impregnated with treprostinil, that can be shaped to the contours of the region to be treated, a so-called “active” electrode in contact with the primary dressing, a so-called “passive” electrode at a distance from the active electrode, a DC generator, the terminals of which are connected to the electrodes, the cathode and the anode respectively forming the active electrode and the passive electrode for iontophoresis, so as to cause treprostinil to migrate by cathodal iontophoresis into the region to be treated.
    Type: Application
    Filed: July 15, 2014
    Publication date: June 9, 2016
    Applicants: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, UNIVERSITE GRENOBLE ALPE
    Inventors: Jean-Luc CRACOWSKI, Matthieu ROUSTIT, Sophie BLAISE